Editorial comment--degree of arterial recanalization: an end point for efficacy in future intravenous thrombolytic trials.
Molina
Carlos A
CA
D001158:Arteries / Q000187:drug effects*; D015415:Biomarkers; D002560:Cerebrovascular Circulation / Q000187:drug effects; D002986:Clinical Trials as Topic / Q000592:standards*; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007275:Injections, Intravenous; D015337:Multicenter Studies as Topic / Q000592:standards; D012720:Severity of Illness Index; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D014654:Vascular Patency / Q000187:drug effects*
D015415:Biomarkers; D005343:Fibrinolytic Agents